Mosaiques Diagnostics

Mosaiques Diagnostics is a world-leading company in omics-based biomarker research, dedicated to advancing precision medicine through clinical proteome analysis. At Mosaiques, we develop multi-marker panels for diagnosis and guiding therapy-decision using AI/ML. Our proprietary hardware and software platforms, combined with a unique database of over proteome profiles, provide one of the most comprehensive resources in clinical proteomics worldwide. This strong foundation enables us to deliver robust and reproducible results that meet the highest scientific and clinical standards. Over the past 20 years, we have collaborated with numerous clinical and academic partners in more than 100 clinical studies, resulting in over 400 scientific publications. Through these efforts, we have developed and registered several in vitro diagnostic tests in Germany and received an FDA Letter of Support for one of our biomarker panels. Mosaiques provides innovative clinical proteomics services to patients, healthcare providers, academic institutions, and pharmaceutical companies. We continue to drive progress in proteomics-based precision medicine, shaping the future of diagnostics and targeted therapy.